Common questions about sample collection, matrix selection, and cytokine measurement in serum and plasma using Luminex multiplex technology.
Should I use serum or plasma for my cytokine study?
The choice depends on your analytes of interest. For most routine cytokine panels (IL-6, TNF-α, IFN-γ, chemokines), both serum and plasma give comparable results if collected and processed consistently. For TGF-β isoforms, PF4, PDGF, or other platelet-enriched analytes, use plasma — serum levels are artifactually elevated 2–5 fold due to platelet degranulation during clotting. The most important rule: choose one matrix and use it consistently for every sample in your study. Never mix serum and plasma in the same analysis.
How much serum or plasma do I need for a Luminex multiplex assay?
The assay requires 25 μL of serum or plasma per well for a full multiplex panel. With duplicates, 50 μL is sufficient. We recommend submitting at least 75–100 μL of each sample to allow for repeat testing if needed. For multi-panel studies (e.g.,
cytokine panel + metabolic panel + checkpoint panel), 25 μL per panel is required from the same sample aliquot or from separate aliquots.
Why are my cytokine levels different from published reference ranges?
Cytokine reference ranges are highly platform-, matrix-, and population-dependent. Differences between your results and published values can arise from: (1) different detection platforms (Luminex vs ELISA vs MSD vs Olink), (2) different antibody clones and standard curves, (3) serum vs plasma, (4) collection and processing protocols, (5) population demographics. Published extracellular cytokine concentrations in healthy serum/plasma often span 10–100 fold across studies for the same analyte. For this reason, we recommend including your own healthy control cohort rather than relying on literature reference ranges alone.
Can hemolyzed samples be used for cytokine measurement?
Mild hemolysis may be acceptable for some analytes, but moderate to severe hemolysis should be avoided. Hemolysis releases intracellular contents from erythrocytes and leukocytes, falsely elevating IL-6, IL-8, and TNF-α. Hemoglobin also absorbs light at the wavelengths used for Luminex fluorescence detection, causing optical interference. If hemolyzed samples must be included, record the hemolysis grade (mild/moderate/severe) for each sample and interpret IL-6, IL-8, and TNF-α results from hemolyzed samples with caution.
How do I handle samples that require DPP-IV inhibitor (for GLP-1, GIP measurement)?
GLP-1 and GIP are rapidly degraded by dipeptidyl peptidase-4 (DPP-IV) with a half-life of <2 minutes in circulation. For accurate incretin measurement, blood must be collected into tubes pre-loaded with a DPP-IV inhibitor (e.g., sitagliptin at 10 μL/mL blood, or a commercial DPP-IV inhibitor cocktail). The inhibitor must be added BEFORE blood collection — adding it after collection is ineffective because degradation occurs within seconds. Without inhibitor, measured GLP-1 will be near or below the detection limit regardless of the actual in vivo concentration. We can provide pre-treated collection tubes upon request.
Can I submit samples that have already undergone freeze-thaw cycles?
Yes, but you must document the number of freeze-thaw cycles for each sample. Each cycle reduces immunoreactivity by 5–15% for most cytokines, with IL-4, IL-17A, IFN-γ, and GLP-1 being most labile. Samples with >3 freeze-thaw cycles should be excluded or analyzed with appropriate caveats. If freeze-thaw history is undocumented, we recommend treating the data as semi-quantitative (rank order comparisons within the study) rather than comparing absolute concentrations to external reference ranges.
What is the minimum project size for serum/plasma Luminex assays?
One 96-well plate. A single plate accommodates 39 samples in duplicate plus a 7-point standard curve and two QC samples. For smaller batches (<39 samples), a plate surcharge applies. For large multi-plate studies, we include a bridge sample on each plate to normalize inter-plate variability. Contact us with your expected sample count for an optimized plate layout and quotation.
How are values below the lower limit of detection (LLOD) reported?
Concentrations below the LLOD are flagged in the final data report. For analytes with <50% of samples above LLOD in your study, we recommend treating the data as categorical (detectable vs. non-detectable) rather than continuous for statistical analysis. This is common for low-abundance cytokines (IL-1β, IL-4, IL-17A) in healthy serum/plasma. If high sensitivity is critical for your study, request a high-sensitivity assay configuration at the inquiry stage — these configurations use extended incubation times and optimized antibody concentrations to lower the LLOD.
Can you run multiple panels from the same serum or plasma sample?
Yes. Each Luminex panel requires only 25 μL of sample. A standard 0.5 mL serum aliquot can support up to 10 separate multiplex panels in duplicate, or 5 panels with sufficient reserve for repeat testing. Common multi-panel combinations include: (1) cytokine panel + metabolic hormone panel, (2) inflammation panel + soluble checkpoint panel, or (3)
Th1/Th2 panel + chemokine panel. We can coordinate all panels from the same sample submission. When submitting samples, indicate which panels you need for each aliquot and we will optimize the plate layout.
How should I ship my serum or plasma samples?
Ship on dry ice in an insulated container with sufficient dry ice to last 48–72 hours plus a 24-hour buffer. Samples must arrive frozen. Include a sample manifest listing each sample ID, collection date/time, matrix type, fasting status, and any processing notes. For international shipments, coordinate with us in advance for any required import permits. Do not ship samples on wet ice or at ambient temperature — cytokines degrade within hours at 4°C and within minutes at room temperature.
